Intact Drugs And Pharmaceuticlas Pvt.Ltd. - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1992.
1992 Delhi, Delhi, India Active
Last Updated:
Access Report
About Intact Drugs And Pharmaceuticlas Pvt.Ltd.

Intact Drugs And Pharmaceuticlas Pvt.Ltd., a active private limited company, was established on 03 March 1992 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230DL1992PTC217567. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.91 M.

It upholds a compliant status. Its leadership includes Naresh Kumar Goyal (Additional Director), Mukesh Kumar (Director), Garima Goswami (Additional Director). Past directors included Vivek Goyal, Naresh Kumar Goyal, Sushil Kumar Batra. It holds ₹1.38 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 1201, 12Th Floor, D Mall, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230DL1992PTC217567

  • Registration Number

    217567

  • Incorporation Date

    03 March 1992

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹1.91 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.91 M
  • Company Age 33 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.38 Cr
  • Revenue Growth **** 42.88%
  • Profit Growth **** 153.59%
  • Ebitda **** 753.46%
  • Net Worth 9.85%
  • Total Assets -10.27%
Company report

Intact Drugs And Pharmaceuticlas Pvt.Ltd.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Intact Drugs And Pharmaceuticlas Pvt.Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Intact Drugs And Pharmaceuticlas Pvt.Ltd.?
Current Directors
Name Designation Appointment Date Status
Naresh Kumar Goyal Additional Director 19 Sep 2024 Current
Mukesh Kumar Director 21 Mar 2023 Current
Garima Goswami Additional Director 30 Oct 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2008 Past
Pramod Abcsdd Director 26 Nov 2009 Past
Pramod Abcsdd Director 30 Nov 2007 Past
Pramod Abcsdd Director 23 Jun 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Intact Drugs And Pharmaceuticlas.Ltd..

Intact Drugs And Pharmaceuticlas Pvt.Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 42.88% increase. The company also saw a substantial improvement in profitability, with a 153.59% increase in profit. The company's net worth moved up by a moderate rise of 9.85%.

Intact Drugs And Pharmaceuticlas.Ltd. revenue growth over time
Intact Drugs And Pharmaceuticlas.Ltd. profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.88%
*******
*******
*******
*******
Revenue from Operations
*******
 39.98%
*******
*******
*******
*******
Total Assets
*******
 -10.27%
*******
*******
*******
*******
Profit or Loss
*******
 153.59%
*******
*******
*******
*******
Net Worth
*******
 9.85%
*******
*******
*******
*******
EBITDA
*******
 753.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Intact Drugs And Pharmaceuticlas.Ltd.?

Unlock access to Intact Drugs And Pharmaceuticlas.Ltd.'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹13,777,351.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 1.38 Cr
Latest Charge Details
Date Lender Amount Status
09 Jan 2024 Axis Bank Limited ₹2.51 M Open
28 Nov 2023 Axis Bank Limited ₹0.57 M Open
12 Jan 2023 Axis Bank Limited ₹1.07 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Intact Drugs And Pharmaceuticlas.Ltd.?

Unlock and access historical data on people associated with Intact Drugs And Pharmaceuticlas.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Intact Drugs And Pharmaceuticlas.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intact Drugs And Pharmaceuticlas.Ltd.'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Intact Drugs And Pharmaceuticlas.Ltd.
Recent Activity within the Organization
  • Director Appointment

    Progress on Garima Goswami was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2025 & has been associated with this company since 3 months 28 days . was documented.

  • Annual General Meeting

    The activity Intact Drugs And Pharmaceuticlas Pvt.Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Director Appointment

    Naresh Kumar Goyal was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Balance Sheet

    The activity Intact Drugs And Pharmaceuticlas Pvt.Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 2.51 M with Charge ID 100892068 was registered on 09 Jan 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.57 M with Charge ID 100852164 was registered on 28 Nov 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Intact Drugs And Pharmaceuticlas Pvt.Ltd.?

The CIN of Intact Drugs And Pharmaceuticlas Pvt.Ltd. is U24230DL1992PTC217567.

Where is Intact Drugs And Pharmaceuticlas Pvt.Ltd. headquartered?

Intact Drugs And Pharmaceuticlas Pvt.Ltd. is headquartered at Unit No. 1201, 12Th Floor, D Mall, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

When was Intact Drugs And Pharmaceuticlas Pvt.Ltd. incorporated?

Intact Drugs And Pharmaceuticlas Pvt.Ltd. was incorporated on 03 March 1992.

Who are the current directors of Intact Drugs And Pharmaceuticlas Pvt.Ltd.?

The current directors of Intact Drugs And Pharmaceuticlas Pvt.Ltd. are

What is the primary industry of Intact Drugs And Pharmaceuticlas Pvt.Ltd.?

The primary industry of Intact Drugs And Pharmaceuticlas Pvt.Ltd. is Trade.

Is Intact Drugs And Pharmaceuticlas Pvt.Ltd. a listed company?

Intact Drugs And Pharmaceuticlas Pvt.Ltd. is unlisted.

What is the capital structure of Intact Drugs And Pharmaceuticlas Pvt.Ltd.?

The authorized capital of Intact Drugs And Pharmaceuticlas Pvt.Ltd. is ₹2.00 M, and the paid-up capital is ₹1.91 M.

What is the compliance status of Intact Drugs And Pharmaceuticlas Pvt.Ltd.?

The compliance status of Intact Drugs And Pharmaceuticlas Pvt.Ltd. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available